Skip to search formSkip to main contentSkip to account menu

etamicastat

Known as: 5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydroimidazole-2-thione 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzopyransImidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey
Abstract 1. The disposition etamicastat was evaluated in the Cynomolgus monkey after intravenous and oral administration of [14C… 
2015
2015
Cardiac safety profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor in non-human primates, human young and elderly healthy volunteers and hypertensive patients
2015
2015
Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor.
2015
2015
Abstract MP13: Etamicastat Prevents Arterial Blood Pressure Increase in Mice Lacking Salt-inducible Kinase 1 (SIK1)
Loss of salt-inducible kinase 1 (SIK1) triggers an increase in blood pressure (BP) upon a chronic high-salt intake in mice (Circ… 
2015
2015
Etamicastat, a new dopamine ß-hydroxylase Inhibitor. Pharmacological characterization
2014
2014
Abstract 505: Effects of Etamicastat, a Selective Peripheral Dopamine-β-Hydroxylase Inhibitor, Upon Stress-induced Changes in Blood Pressure in the SHR
Stressors induce an overactivation of the sympathetic nervous system (SNS) that triggers several changes in the body as a… 
2012
2012
950 HUMAN PHARMACOKINETICS, METABOLISM AND EXCRETION OF ETAMICASTAT, A REVERSIBLE DOPAMINE ß-HYDROXYLASE INHIBITOR
Objectives: Absorption, distribution, metabolism and excretion of etamicastat ((R)-5-(2-aminoethyl)-1-(6,8-difluorochroman-3-yl… 
2011
2011
Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)